Industries de la santé
US to lose dominance of global generics market as emerging economies take over, says GBI Research survey
05 Octobre 2016
London – 4 October 2016 - Although the US is currently the largest generic drugs market by revenue globally, this is expected to change gradually, and dominance will soon shift to emerging markets including India, China, and Brazil, according to a survey from business intelligence provider GBI Research. |The company’s latest report states that, according to an extensive survey of 47...
Plus d'articles...
- BIOCORP et le laboratoire Aguettant s'allient pour améliorer la prise en charge des patients atteints de la maladie de Parkinson
- Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint
- CENTOGENE's genomic database allows decoding rare genetic information - CentoMD® 3.1 burst the 100,000 real case line
- ABIVAX et le CNRS inaugurent un Laboratoire coopératif à Montpellier